Mr1979, Maybe our best hope is that Pfizer understands what Vascepa is
and what it does. Maybe they will end up caring more than our old
management did. One very important concept that AMRN failed to get
across is that the longer a patient is using Vascepa, the greater the
health benefit that will accrue from being on it. AMRN management did
not understand what to do with Vascepa or how to effectively market it.
Maybe KM will figure it out. Pfizer may also be working on it for
Canada. Another failure is the inability of AMRN to distinguish their
product from all of the junk Omega-3 products, from generic V and L to
all of the fish oil products out there that may do more harm than any
good. Thero had no leadership skills and he was inept at running
a Pharma company. I honestly believed that it did not matter because
I was convinced a BO was the only logical solution. I was wrong.